Loading...
Please wait, while we are loading the content...
Similar Documents
Health-Related Quality of Life in Tuberculosis Patients in Eritrea: Comparison Among Drug-Susceptible and Rifampicin/Multidrug-Resistant Tuberculosis Patients.
| Content Provider | Europe PMC |
|---|---|
| Author | Araia, Zenawi Zeramariam Mesfin, Araia Berhane Mebrahtu, Amanuel Hadgu Tewelde, Adiam Ghebreyohanns Tewelde, Asmerom Tesfagiorgis Ngusbrhan Kidane, Solyana |
| Copyright Year | 2021 |
| Abstract | BackgroundDespite the negative impact of tuberculosis (TB) on patients’ quality of life, TB control programs focus on biological and clinical parameters to manage and monitor TB patients. In our setting, patients’ perception of their experience with TB and the impacts of TB on patients’ physical, mental, and social wellbeing remain unknown.ObjectiveThe objective of this study was to evaluate the health-related quality of life (HRQOL) among rifampicin/multidrug-resistant TB (RR/MDR-TB) in comparison to drug-susceptible TB (DS-TB) patients in Eritrea.MethodsA cross-sectional study was conducted in RR/MDR-TB and DS-TB patients under treatment. Anonymized data collected using the WHOQOL-BREF questionnaire were analyzed using SPSS version 23. Frequency, mean and standard deviation were used to describe the data. Mean group score comparison and relationship between variables were assessed using t-test. Domain score was calculated with a mean score of items within each domain and scaled positively, a higher (increasing) score denoting a higher quality of life. Internal consistency was measured using Cronbach’s alpha and statistical significance was set at p < 0.05.ResultsA total of 92 patients (46 RR/MDR-TB and 46 DS-TB) participated in the study. Environmental (40.63 ± 10.72) and physical domains (61.80 ±17.18) were the two most affected domains in RR/MDR-TB and DS-TB patients, respectively. The psychological domain was the least affected domain in RR/MDR-TB (48.28 ± 20.83) and DS-TB patients (76.63 ±15.32). RR/MDR-TB patients had statistically lower mean scores in all domains than DS-TB patients.ConclusionHRQOL was impaired in both groups, but RR/MDR-TB patients had a worse health-related quality of life. |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC8254609&blobtype=pdf |
| Page Count | 8 |
| Journal | Patient Related Outcome Measures [Patient Relat Outcome Meas] |
| Volume Number | 12 |
| PubMed Central reference number | PMC8254609 |
| PubMed reference number | 34234605 |
| e-ISSN | 1179271X |
| DOI | 10.2147/prom.s316337 |
| Language | English |
| Publisher | Dove |
| Publisher Date | 2021-06-29 |
| Access Restriction | Open |
| Rights License | This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). © 2021 Araia et al. |
| Subject Keyword | quality of life multidrug-resistant TB patient-reported outcome end TB sub-Saharan Africa |
| Content Type | Text |
| Resource Type | Article |
| Subject | Medicine |
